Well I went out on a limb two weeks ago and disclosed my train of thinking on this stock. Just when you think you got it figured out it takes a about turn. The news releases have been coming much faster lately and none of it has had an effect on the SP. We are in the slow bleed period until at least the end of the month is my thinking and I hope I am wrong. This change in the royality paid to Zenith should help RVX's SP but the market doesn't seem to reflect it, although it hasn't been approved yet. As we wait for the announcement of the detailes of the Bom trial I am wondering if there will be an offer to purchase RVX between now and the July close on the Hepalink deal. I am more incline to think that Resverlogix is still waiting on FDA approval of the BOM trial as a P III trial. I think this is a stretch but maybe the fast track request as well is being pondered. I'm holding every share and am all in on this one. Good luck to all in the coming weeks, I have no doubt we will start a steep climb in the next six weeks.